Published On:
September 1, 2023
Summary
Characterization and assigning the proper regulatory classification to digital health technologies are critical tasks. This white paper describes obstacles that can be encountered when a product or part of a product is mischaracterized by a manufacturer who determines its technology does not fall under the regulatory oversight of the Food and Drug Administration (FDA). It also offers regulatory insights and tips to navigate complexities effectively.
.png)
.svg.png){kind=logo}